Abstract
Aim:
To investigate the effect of farrerol, a major active component isolated from a traditional Chinese herb “Man-shan-hong” (the dried leaves of Rhododendron dauricum L) on fetal bovine serum (FBS)-induced proliferation of cultured vascular smooth muscle cells (VSMCs) of rat thoracic aorta.
Methods:
VSMCs proliferation, DNA synthesis and cell cycle progression were studied using the MTT assay, bromodeoxyuridine (BrdU) incorporation and flow cytometry, respectively. The mRNA levels of cell cycle proteins were quantified using real-time RT-PCR, and the phosphorylation of ERK1/2 was determined using Western blotting. Reporter gene and receptor binding assays were employed to study the interaction between farrerol and estrogen receptors (ERs).
Results:
Farrerol (0.3–10 μmol/L) inhibited VSMC proliferation and DNA synthesis induced by 5% FBS in a concentration-dependent manner. The effects were associated with G1 cell cycle arrest, down-regulation of cell cycle proteins and reduction in FBS-induced ERK1/2 phosphorylation. Using a reporter gene, it was found that farrerol (3 μmol/L) induced 2.1-fold transcription of ER. In receptor binding assays, farrerol inhibited the binding of [3H]estradiol for ERα and ERβ with IC50 values of 57 μmol/L and 2.7 μmol/L, respectively, implying that farrerol had a higher affinity for ERβ. Finally, the inhibition of VSMC proliferation by farrerol (3 μmol/L) was abolished by the specific ERβ antagonist PHTPP (5 μmol/L).
Conclusion:
Farrerol acts as a functional phytoestrogen to inhibit FBS-induced VSMC proliferation, mainly via interaction with ERβ, which may be helpful in the treatment of cardiovascular diseases related to abnormal VSMCs proliferation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Rivard A, Andres V . Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases. Histol Histopathol 2000; 15: 557–71.
Andres V, Castro C . Antiproliferative strategies for the treatment of vascular proliferative disease. Curr Vasc Pharmacol 2003; 1: 85–98.
Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453–61.
Dubey RK, Gillespie DG, Mi Z, Rosselli M, Keller PJ, Jackson EK . Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway. Hypertension 2000; 35: 262–6.
Akishita M, Ouchi Y, Miyoshi H, Kozaki K, Inoue S, Ishikawa M, et al. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 1997; 130: 1–10.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–33.
Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12.
Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006; 166: 357–65.
Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591–602.
Dubey RK, Gillespie DG, Imthurn B, Rosselli M, Jackson EK, Keller PJ . Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells. Hypertension 1999; 33: 177–82.
Grainger DJ, Metcalfe JC . Tamoxifen: teaching an old drug new tricks? Nat Med 1996; 2: 381–5.
Cerquetani E, Vitale C, Mercuro G, Fini M, Zoncu S, Rosano GM . Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk. Gynecol Endocrinol 2004; 18: 291–8.
Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M . Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006; 113: 1034–44.
Cassidy A, Hooper L . Phytoestrogens and cardiovascular disease. J Br Menopause Soc 2006; 12: 49–56.
Kim SY, Jin YR, Lim Y, Kim JH, Cho MR, Hong JT, et al. Inhibition of PDGFβ-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth muscle cells by kaempferol. Planta Med 2005; 71: 599–603.
Ibarra M, Perez-Vizcaino F, Cogolludo A, Duarte J, Zaragoza-Arnaez F, Lopez-Lopez JG, et al. Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atria. Planta Med 2002; 68: 307–10.
Cao Y, Lou C, Fang Y, Ye J . Determination of active ingredients of Rhododendron dauricum L by capillary electrophoresis with electrochemical detection. J Chromatogr A 2002; 943: 153–7.
Peng YY, Liu FH, Ye JN . Determination of bioactive flavonoids in Rhododendron dauricum L by capillary electrophoresis with electrochemical detection. Chromatographia 2004; 60: 597–602.
Cao Y, Chu Q, Ye J . Chromatographic and electrophoretic methods for pharmaceutically active compounds in Rhododendron dauricum. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 812: 231–40.
Rodriguez A, Fortuno A, Gomez-Ambrosi J, Zalba G, Diez J, Fruhbeck G . The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 2007; 148: 324–31.
Sasu S, LaVerda D, Qureshi N, Golenbock DT, Beasley D . Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 2001; 89: 244–50.
Pizarro JG, Yeste-Velasco M, Esparza JL, Verdaguer E, Pallas M, Camins A, et al. The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res 2008; 45: 8–16.
Watanabe T, Akishita M, Nakaoka T, Kozaki K, Miyahara Y, He H, et al. Estrogen receptor β mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation. Cardiovasc Res 2003; 59: 734–44.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001; 25: 402–8.
Nelson PR, Yamamura S, Mureebe L, Itoh H, Kent KC . Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg 1998; 27: 117–25.
Yoon BK, Oh WJ, Kessel B, Roh CR, Choi D, Lee JH, et al. 17β-Estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism. Menopause 2001; 8: 58–64.
Geraldes P, Sirois MG, Tanguay JF . Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res 2003; 93: 399–405.
Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andres V . Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res 1997; 80: 418–26.
Adam RM, Borer JG, Williams J, Eastham JA, Loughlin KR, Freeman MR . Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate. Endocrinology 1999; 140: 5866–75.
Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med 1997; 3: 545–8.
Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, et al. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci U S A 1999; 96: 15133–6.
Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME . Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 1998; 83: 224–9.
Crisafulli A, Altavilla D, Marini H, Bitto A, Cucinotta D, Frisina N, et al. Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 2005; 12: 186–92.
Goodman-Gruen D, Kritz-Silverstein D . Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 2001; 131: 1202–6.
Acknowledgements
We are indebted to Drs Tao HE and Dale E MAIS for valuable comments on this manuscript. The study was supported in part by grants from the Ministry of Science and Technology of China (No 2009ZX09302-001) and Shanghai Municipality Government (No 08DZ2291300 and 09DZ2291200).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Qy., Chen, L., Zhu, Yh. et al. Involvement of estrogen receptor-β in farrerol inhibition of rat thoracic aorta vascular smooth muscle cell proliferation. Acta Pharmacol Sin 32, 433–440 (2011). https://doi.org/10.1038/aps.2011.1
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2011.1
Keywords
This article is cited by
-
Natural flavonoid silibinin promotes the migration and myogenic differentiation of murine C2C12 myoblasts via modulation of ROS generation and down-regulation of estrogen receptor α expression
Molecular and Cellular Biochemistry (2020)
-
Farrerol maintains the contractile phenotype of VSMCs via inactivating the extracellular signal-regulated protein kinase 1/2 and p38 mitogen-activated protein kinase signaling
Molecular and Cellular Biochemistry (2020)
-
Correlation between insulin-induced estrogen receptor methylation and atherosclerosis
Cardiovascular Diabetology (2016)
-
Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice
BMC Complementary and Alternative Medicine (2015)
-
Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay
Acta Pharmacologica Sinica (2014)
